NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Industry news  «  1  2  3  4  5  » 
found files: 758
»06/07/2007 [Industry news]
New death card dealt in China drug scandal

06/07/2007 - A second former State Food and Drug Administration (SFDA) official was slammed with the death penalty over a corruption scandal that first broke last year....   more»

»10/07/2007 [Industry news]

A senior Chinese food regulator has warned that problems with food safety in the country could cause diseases and threaten social stability....   more»

»11/07/2007 [Industry news]
China\\\'s pharmaceutical watchdog vows to tighten approval procedures

China\\\'s pharmaceutical watchdog will tighten the approval procedures for new medicines with the revised regulation on medicine registration taking effect on Oct. 1....   more»

»12/07/2007 [Industry news]
China Says Halting Fake Medicine Will Take 5 Years

China, facing international criticism over the quality of food and drug exports, said it will take five years to stamp out production of fake medicine and that the trend in safety is not promising....   more»

»06/07/2007 [Industry news]
China tightens quality control of pharmaceutical firms

China food and drug watchdog has revoked the production licenses of five drug manufacturers since last July....   more»

»11/07/2007 [Industry news]
The Chemical Industry in China Accounts for 10% of the Country’s GDP

The chemical industry is the third largest in China, after textiles and machinery, and accounts for 10% of the country’s GDP, as well as for between 35% and 40% of the global demand growth for chemicals. China’s chemical industry is the second largest consumer, after the US, of basic chemical products - fully 45% of the total for Asia. The estimated growth in domestic demand for chemicals in 2005-2006 is now estimated at seven to eight percent...   more»

»02/08/2007 [Industry news]
China has last laugh

In February of this year, following several years of frenzied increase, a one-day 8% decline in the markets in China caused jitters throughout the world. Pundits responded by using the derogatory term bubble to describe China’s stock market. But China recovered from that decline – and from several other smaller, subsequent ones – and now finds itself, once again, at record levels....   more»

»18/07/2007 [Industry news]
Chinese Biotech Week in Review: Safety News Dominates

ChinaBio Today submits: The execution of former head of the Chinese FDA, Zheng Xiaoyu, for bribery was the big story last week in the world of Chinese biotech (see story). To Americans, the story was shocking, both because death sentences are not meted out for white collar crimes in the U.S., and because of the speed with which the sentence was carried out. How long does the average prisoner sit on death row in the U.S.? While Zheng appealed the sentence (though not the verdict), the appeal was heard in six weeks time, and Zheng was summarily executed immediately after the decision was handed down. A written confession from Zheng was published, in which he admitted actions that led the deaths of at least 10 individuals...   more»

»03/08/2007 [Industry news]
Du Pont Settles lawsuit with China company

NEW YORK - Chemical maker DuPont Co. on Wednesday said it settled a patent infringement lawsuit filed this year against Chinese chemical maker Trustchem Co. Ltd., also known as Jiangsu Trustchem Chemicals Co....   more»

Novartis »08/08/2007 [Industry news]
MNCs may go to China for R&D

NEW DELHI: Multinational drug makers would prefer China for investments in pharmaceutical research so long as India keeps the bar for patenting a drug so high, warns drug major Novartis on Monday after the Madras High Court turned down the company\'s challenge to the country’s patent law....   more»

»15/08/2007 [Industry news]
Five global giants opt for China over India for R&D units

Five multinational pharmaceutical companies have preferred China over India for setting up research and development units due to the inadequacies in India\'s patent laws. Besides Novartis, the other companies are Roche, J&J, Glaxo and Astrazeneca, Ranjit Shahani, managing director of the Indian arm of Swiss multinational Novartis, said the R&D focus of all these centres, set up during the last two years, were mostly tropical diseases, or, diseases of the developing world. Shahani is also the president of the Organisation of Pharmaceutical Producers of India (OPPI), which represents multinational pharma companies....   more»

»18/08/2007 [Industry news]
UK to establish Confucius Institute for Chinese Medicine

Britain is to establish a Confucius Institute for Chinese Medicine, the first in the world which offers courses in Chinese medicine....   more»

»23/08/2007 [Industry news]

Since the scandal at the SFDA, approval process in China has been largely delayed. It affects almost every aspect in the industry, such as approval for new drug,...   more»

»30/08/2007 [Industry news]
Philips, IHS to set up joint research lab in Shanghai

Electronics giant Royal Philips and Institute of Health Sciences (IHS), a part of the Shanghai Institutes for Biological Sciences (SIBS) and affiliated to the Shanghai Jiao Tong University School of Medicine, will establish a joint research laboratory within the IHS in Shanghai, China. The joint laboratory will conduct advanced research in the field of molecular medicine and is aimed at biomarker discovery and test development for next-generation in vitro diagnostic testing....   more»

»29/08/2007 [Industry news]
Philips and the Institute of Health Sciences Join Forces in Molecular Medicine

SHANGHAI, China--(BUSINESS WIRE)--Royal Philips Electronics and the Institute of Health Sciences (IHS) today announced an agreement to establish a joint research laboratory within the IHS in Shanghai, China. The IHS is part of the Shanghai Institutes for Biological Sciences (SIBS) and is also affiliated to the Shanghai Jiao Tong University School of Medicine. The joint laboratory will conduct advanced research in the field of molecular medicine....   more»

»16/09/2007 [Industry news]
Blood products to face testing from 2008

China will begin compulsory testing on every batch of blood products from January 1, 2008, as one of its latest moves to tighten supervision of blood and biological products, according to the State Food and Drug Administration (SFDA)....   more»

»14/09/2007 [Industry news]
Sartorius inaugurates new plant in China

In his address, Dr Kreuzburg said thanks to its long-standing presence in China, Sartorius had gained high brand awareness and enjoys a strong market position with customers from the pharmaceutical, chemical and food industries. "Particularly for the growth of our Mechatronics Division, Asia plays a decisive role," said Dr Kreuzburg. "After we have already been highly successful with lab balances throughout a decade, our business with industrial weighing equipment is now also developing at a rapid pace. We are profiting from the high investments of global groups in China by covering their needs for weighing equipment in their on-site production processes."...   more»

»12/09/2007 [Industry news]
China R & D Investment at all time high

China invested 300.31 billion yuan (39.9 billion U.S. dollars) in research and development (R&D)last year as it boosted science and technology innovation to develop a more sustainable economy. The R&D investment jumped by an annual rate of 22.6 percent, or 55.31 billion yuan, according to a statement jointly released by the National Bureau of Statistics, the Ministry of Science and Technology, and the Ministry of Finance on Wednesday. The spending accounted for 1.42 percent of the gross domestic product in the world's fastest-growing major economy in 2006, the highest proportion ever, the statement noted. China has set the target of investing two percent of its GDP in the R&D by 2010, according to the 11th Five-Year Program for National Economic and Social Development (2006--2010). R&D spending by companies hit 213.45 billion yuan, accounting for 71.1 percent of the total, according to the statement. Government research agencies spent 56.7 billion yuan and higher education institutions 27.7 billion yuan, accounting for 18.9 and 9.2 percent respectively. About 234.28 billion yuan, or 78 percent of China's total R&D spending went on development work, but only 16.8 percent went on application research and 5.2 percent went on basic scientific research. The pharmaceutical, special instruments, electrical machinery, general instruments, transport manufacturing, rubber, and electronics sectors spent more than one percent of their sales revenues on R&D. The government earmarked 168.9 billion yuan for the science and technology front, up 26.5 percent, or 35.36 billion yuan, from 2005. The sum was 4.2 percent of the government's total expenditure last year, the highest since 1998....   more»

»15/10/2007 [Industry news]
SFDA Announces reduction in approval times and US SFDA to accept china data

reducing the target for approval to four months from a range of eight to twelve months. Also confirmed was that the US FDA will start accepting all-China data as a basis for approval of drugs. The news will have the effect of increasing the allure of conducting clinical trials in China....   more»

»06/10/2007 [Industry news]
Ranbaxy Laboratories, India\\\'s largest drug maker, is planning to set up a joint venture in China to manufacture active pharmaceutical ingredients (APIs) used in drug manufacturing.

Ranbaxy Laboratories, India\\\'s largest drug maker, is planning to set up a joint venture in China to manufacture active pharmaceutical ingredients (APIs) used in drug manufacturing. We are currently talking to two-three large API manufacturers from China and also evaluating various other options. It is too early to divulge more details and name of the companies, said Naresh Kumar, senior vice-president, API research and manufacturing business, Ranbaxy Laboratories, on the sidelines of CPhI Worldwide, the annual pharmaceutical exhibition at Milan....   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.